Jynneos vaccine crucial for preventing monkeypox spread

pharmaceutical-technology.com

Bavarian Nordic's Jynneos vaccine, distributed by Morris & Dickson, is crucial for preventing monkeypox spread. The vaccine, stored at -25°C to -15°C, gained FDA approval in 2019 and CDC recommendation in 2023. Based on a non-replicating virus strain, Jynneos contributed significantly to Bavarian Nordic's $1bn revenue in 2023. Morris & Dickson's unique distribution capabilities play a key role in ensuring equitable access to healthcare.


With a significance score of 3.7, this news ranks in the top 7.1% of today's 28794 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: